1. Home
  2. RFL vs VNRX Comparison

RFL vs VNRX Comparison

Compare RFL & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • VNRX
  • Stock Information
  • Founded
  • RFL 2017
  • VNRX N/A
  • Country
  • RFL United States
  • VNRX United States
  • Employees
  • RFL 31
  • VNRX N/A
  • Industry
  • RFL Real Estate
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • RFL Finance
  • VNRX Health Care
  • Exchange
  • RFL Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • RFL 67.7M
  • VNRX 52.4M
  • IPO Year
  • RFL N/A
  • VNRX N/A
  • Fundamental
  • Price
  • RFL $1.90
  • VNRX $0.67
  • Analyst Decision
  • RFL
  • VNRX Strong Buy
  • Analyst Count
  • RFL 0
  • VNRX 5
  • Target Price
  • RFL N/A
  • VNRX $3.88
  • AVG Volume (30 Days)
  • RFL 440.7K
  • VNRX 324.9K
  • Earning Date
  • RFL 06-11-2025
  • VNRX 08-13-2025
  • Dividend Yield
  • RFL N/A
  • VNRX N/A
  • EPS Growth
  • RFL N/A
  • VNRX N/A
  • EPS
  • RFL N/A
  • VNRX N/A
  • Revenue
  • RFL $732,000.00
  • VNRX $1,308,361.00
  • Revenue This Year
  • RFL N/A
  • VNRX $563.72
  • Revenue Next Year
  • RFL N/A
  • VNRX $160.43
  • P/E Ratio
  • RFL N/A
  • VNRX N/A
  • Revenue Growth
  • RFL 35.56
  • VNRX 64.16
  • 52 Week Low
  • RFL $1.27
  • VNRX $0.40
  • 52 Week High
  • RFL $3.19
  • VNRX $0.94
  • Technical
  • Relative Strength Index (RSI)
  • RFL 53.05
  • VNRX 53.14
  • Support Level
  • RFL $1.81
  • VNRX $0.62
  • Resistance Level
  • RFL $2.04
  • VNRX $0.76
  • Average True Range (ATR)
  • RFL 0.16
  • VNRX 0.10
  • MACD
  • RFL 0.00
  • VNRX -0.02
  • Stochastic Oscillator
  • RFL 71.43
  • VNRX 32.00

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: